Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

Conditions:   Gastric Cancer;   Stomach Cancer;   Esophageal Cancer
Intervention:   Drug: Margetuximab in Combination with Pembrolizumab
Sponsors:   MacroGenics;   Merck Sharp & Dohme Corp.
Recruiting - verified February 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1ozoqkn
via IFTTT